Maternal Circulating Levels Of Transforming Growth Factor-Beta Superfamily And Its Soluble Receptors In Hypertensive Disorders Of Pregnancy

Objective To assess circulating levels of transforming growth factor (TGF)-beta superfamily members and their soluble receptors in hypertensive disorders of pregnancy, and to investigate associations with clinical manifestations.Methods A retrospective study was conducted using data for women admitted to a center in China for delivery between May 2011 and April 2013. Women with severe pre-eclampsia, mild pre-eclampsia, and gestational hypertension were included, along with a control group. Serum levels of activin A, inhibin A, TGF-1, soluble endoglin (sEng), and soluble betaglycan (sBG) were measured.Results Women with severe pre-eclampsia (n=17) had higher mean levels of activin A (23.52.1 g/L), inhibinA (1.70.2 g/L), sEng (32.1 +/- 3.2 g/L), and sBG (84.1 +/- 9.4 g/L) than did normotensive controls (n=18), women with gestational hypertension (n=15), and those with mild pre-eclampsia (n=14; all P<0.05). Women with early-onset pre-eclampsia (n=13) had higher levels of these serum markers than did preterm normotensive controls (n=8; all P<0.001). Women with severe or early-onset pre-eclampsia had the lowest TGF-1 levels. Activin A, inhibin A, sEng, and sBG levels were positively correlated with mean arterial pressure and proteinuria (all P<0.01).Conclusion Pre-eclampsia is associated with an imbalance of members of the TGF-beta superfamily and their soluble receptors, which might contribute to the development of pre-eclampsia and help to predict onset and severity.